Oncology & Cancer

VCP protein inhibitor found to help virus kill liver tumors

(Medical Xpress)—A team of researchers with members from several institutions in China has found that combining a VCP protein inhibitor with a virus that naturally targets liver cancer tumors made the virus much more potent. ...

Oncology & Cancer

Stem cell-based therapy for targeting skin-to-brain cancer

Investigators from Brigham and Women's Hospital (BWH) and the Harvard Stem Cell Institute have a potential solution for how to kill tumor cells that have metastasized to the brain. The team has developed cancer-killing viruses ...

Oncology & Cancer

Combining immunotherapies effective against mouse model of cancer

Rhabdomyosarcoma, a cancer made up of cells that normally develop into skeletal muscles, is the most common soft tissue cancer in children. If it is detected early and localized in certain areas, rhabdomyosarcoma is usually ...

Oncology & Cancer

Adenoviruses and the immune system join forces against cancer

Researchers of the Cancer Virotherapy Research Group of Bellvitge Biomedicine Research Institute (IDIBELL), led by Dr. Ramon Alemany, have developed an oncolytic virus capable of redirecting the patient's immune system against ...

Oncology & Cancer

OVC cancer breakthrough leads to human clinical trials

Cancer treatment in people could be transformed thanks to a study on treating cancer in animals led by researchers from the Ontario Veterinary College (OVC) at the University of Guelph.

page 4 from 5